Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-005461
Filing Date
2023-02-17
Accepted
2023-02-17 16:43:55
Documents
1
Period of Report
2022-12-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5081
  Complete submission text file 0001493152-23-005461.txt   6674
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Issuer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SONNET BIOTHERAPEUTICS HOLDINGS, INC 100 OVERLOOK CENTER PRINCETON NJ 08540
Business Address
Griffith Donald J. (Reporting) CIK: 0001663251 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35570 | Film No.: 23643380